According to TTC groups, the service includes,
- Thorough technology and market assessments for commercial/investor interest
- Evaluation and recommendation of appropriate funding scenarios and deal structure:
- Strategic (corporate and corporate venture funds)
- Private equity
- Venture capital and specialty Life Sciences hedge fund market investors
- Patient and disease advocacy groups
- Segment angel
- New (stand-alone) company vs. licensing of technology(ies)
- Valuation of up-front investment, milestone payments, maintenance fees royalty structure, etc.
- Create detailed pro-forma financial models with scenario analyses, incorporating market models into revenue build
- Packaging commercial strategy and value propositions for recommended capital vehicle and deal structure, including preparation of robust business/development plan(s) to support raise, accompanied by non-confidential and confidential marketing materials
- Developing the funding strategy and contact lists
- Assembly of Offering Memorandum documents; review by legal counsel and auditors, as needed
- Presentation of investment opportunity to targeted investors/strategic partners
- Negotiation of deal terms with interested investors
- Search and recommend CEO/CFO/Senior management, as appropriate
- Search and recruit Scientific Advisory Board, as appropriate
- Search and recruit Board of Directors from non-investors, as appropriate
- Executing the commercial strategy—including dimensionalizing the technology and value propositions, and packaging the corporate entity—in an ongoing manner intended to increase valuation, engineer consent amongst gatekeeper constituents and steward the evolution of the company and its technology portfolio
No comments:
Post a Comment